Detalles de la búsqueda
1.
Bone-modifying agents are protective for symptomatic skeletal events in Radium-223 treatment.
Int J Urol
; 30(11): 1029-1034, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37501328
2.
Effectiveness and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases in real-world practice: A multi-institutional study.
Int J Urol
; 30(2): 139-146, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305673
3.
Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Jpn J Clin Oncol
; 52(12): 1430-1435, 2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36093731
4.
Triple Therapy with Tamsulosin, Dutasteride, and Imidafenacin for Benign Prostatic Hyperplasia in Patients with Overactive Bladder Symptoms Refractory to Tamsulosin: Subgroup Analyses of the DIrecT Study.
Urol Int
; 105(9-10): 817-825, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33690238
5.
Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study.
Anticancer Drugs
; 31(3): 298-303, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31913197
6.
Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).
Int J Urol
; 26(3): 342-352, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548692
7.
Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study).
Int J Urol
; 24(7): 525-531, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28466585
8.
Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study).
BJU Int
; 116(4): 612-22, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25639296
9.
Once-daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post-hoc analysis of a phase III randomized clinical trial.
Int J Urol
; 22(7): 684-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25782032
10.
Non-inferiority of silodosin 4 mg once daily to twice daily for storage symptoms score evaluated by the International Prostate Symptom Score in Japanese patients with benign prostatic hyperplasia: a multicenter, randomized, parallel-group study.
Int J Urol
; 22(3): 311-6, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25597862
11.
Phase III, randomised, double-blind, placebo-controlled study of the ß3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder.
BJU Int
; 113(6): 951-60, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24471907
12.
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study.
Curr Oncol
; 31(2): 862-871, 2024 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38392058
13.
Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study.
Anticancer Res
; 43(10): 4701-4708, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772560
14.
Obstruction enhances rho-kinase pathway and diminishes protein kinase C pathway in carbachol-induced calcium sensitization in contraction of α-toxin permeabilized guinea pig detrusor smooth muscle.
Neurourol Urodyn
; 31(4): 593-9, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22396250
15.
A prospective, single-center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180-W GreenLight XPS laser, a 300-W diode laser, and a 200-W thulium laser for the treatment of benign prostatic hyperplasia.
Low Urin Tract Symptoms
; 14(5): 373-379, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35719056
16.
External Validation of a Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Patients Receiving Post-Docetaxel Second-Line Chemotherapy.
JMA J
; 5(2): 224-229, 2022 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35611227
17.
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab.
Cancer Manag Res
; 14: 1641-1651, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35535266
18.
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study.
Clin Genitourin Cancer
; 20(5): 499.e1-499.e8, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35624001
19.
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status.
Onco Targets Ther
; 15: 1321-1330, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36388155
20.
Diphosphate regulation of adenosine triphosphate sensitive potassium channel in human bladder smooth muscle cells.
J Urol
; 186(2): 736-44, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21683406